Skip to content

2 Market-Beating Stocks With Major Catalysts On The Way

For those seeking stocks that have trounced the market over the past year, the biotech sector might be an excellent place to start. The SPDR S&P Biotech Index ETF, an industry benchmark, has climbed 34% over the trailing-12-month period, nearly three times the gains of the S&P 500.

These two drugmakers that have done particularly well for themselves. Moreover, both companies expect catalysts that could send their results even higher. Let’s consider whether that makes either stock a buy.

This post originally appeared at The Motley Fool.